Related references
Note: Only part of the references are listed.Disruption of GRM1-mediated signalling using riluzole results in DNA damage in melanoma cells
Brian A. Wall et al.
PIGMENT CELL & MELANOMA RESEARCH (2014)
Functional Effects of GRM1 Suppression in Human Melanoma Cells
Janet Wangari-Talbot et al.
MOLECULAR CANCER RESEARCH (2012)
Glutamatergic signaling in cellular transformation
Jessica L. F. Teh et al.
PIGMENT CELL & MELANOMA RESEARCH (2012)
Riluzole Enhances Ionizing Radiation-Induced Cytotoxicity in Human Melanoma Cells that Ectopically Express Metabotropic Glutamate Receptor 1 In Vitro and In Vivo
Atif J. Khan et al.
CLINICAL CANCER RESEARCH (2011)
Glutamatergic Pathway Targeting in Melanoma: Single-Agent and Combinatorial Therapies
Hwa Jin Lee et al.
CLINICAL CANCER RESEARCH (2011)
A Phase 0 Trial of Riluzole in Patients with Resectable Stage III and IV Melanoma
Dana Yip et al.
CLINICAL CANCER RESEARCH (2009)
Metabotropic glutamate receptor subtype-1 is essential for in vivo growth of melanoma
Y. Ohtani et al.
ONCOGENE (2008)
Metabotropic glutamate receptor 1 and glutamate signaling in human melanoma
Jin Namkoong et al.
CANCER RESEARCH (2007)
Combined-modality therapy for patients with regional nodal metastases from melanoma
MT Ballo et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
Survival following whole brain radiation treatment for cerebral metastases: an audit of 474 patients
AM Broadbent et al.
RADIOTHERAPY AND ONCOLOGY (2004)
Melanoma mouse model implicates metabotropic glutamate signaling in melanocytic neoplasia
PM Pollock et al.
NATURE GENETICS (2003)
Share Paper
